Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic

Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, ...
TCTMD

STUN-AF: Ablation Before LAAO May Reduce Peridevice Leaks

The approach should be considered to prevent leaks, which have been tied to increased stroke risks, Vivek Reddy says.
Medical Device and Diagnostic Industry (MD+DI)

Edwards Lifesciences Crashes the LAA Party: Can the TAVR Giant Compete?

Edwards Lifesciences secures FDA clearance for its ECLIPTIS Left Atrial Appendage Exclusion System, entering a competitive ...
MedPage Today on MSN

Pulsed field ablation tied to fewer LAA occluder leaks

Operators come to grips with LAA contractility in observational study ...
Healio

Left atrial appendage closure may not confer benefit vs. drug therapy in high-risk AF

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation and high risk for stroke and bleeding, left atrial appendage occlusion was ...
Medical Xpress

Examining percutaneous left atrial appendage occlusion therapy

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is increasing in incidence and prevalence worldwide. AF significantly increases the risk of intracardiac thrombus formation and, ...
Nature

Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges

Atrial fibrillation (AF) is a major risk factor for disabling ischemic strokes. Anticoagulation is highly effective for stroke prevention in patients with AF, but a substantial number of patients are ...
Medscape

Amulet and Watchman Equal for Left Atrial Appendage Closure

SAN FRANCISCO — Thirteen months after percutaneous left atrial appendage closure (LAAC), outcomes did not differ whether closure was performed using the Amulet (Abbott Cardiovascular) or the Watchman ...